Availability of Draft Toxicological Profiles, 20359-20360 [2019-09538]

Download as PDF Federal Register / Vol. 84, No. 90 / Thursday, May 9, 2019 / Notices A. Federal Reserve Bank of Minneapolis (Mark A. Rauzi, Vice President), 90 Hennepin Avenue, Minneapolis, Minnesota 55480–0291: 1. Stephen K. Hayes, Presho, South Dakota, individually and as trustee of the Margery I. Hayes Trust, Fort Pierre, South Dakota and Stephen K. Hayes, Margery I. Hayes Trust, Mary A. Dott, Sioux Falls, South Dakota, and JoAnne M. Wingert, Benton City, Washington, as a group acting in concert; to retain voting shares of Draper Holding Company, Inc., Fort Pierre, South Dakota, and thereby indirectly retain shares of Dakota Prairie Bank, Fort Pierre, South Dakota. President) 1 Memorial Drive, Kansas City, Missouri 64198–0001: 1. BancFirst Corporation, Oklahoma City, Oklahoma; to acquire voting shares of Pegasus Bank, Dallas, Texas. Board of Governors of the Federal Reserve System, May 6, 2019. Yao-Chin Chao, Assistant Secretary of the Board. [FR Doc. 2019–09561 Filed 5–8–19; 8:45 am] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES Board of Governors of the Federal Reserve System, May 6, 2019. Yao-Chin Chao, Assistant Secretary of the Board. Agency for Toxic Substances and Disease Registry [FR Doc. 2019–09563 Filed 5–8–19; 8:45 am] Availability of Draft Toxicological Profiles BILLING CODE P [Docket No. ATSDR–2019–0006] Agency for Toxic Substances and Disease Registry (ATSDR), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: FEDERAL RESERVE SYSTEM jbell on DSK3GLQ082PROD with NOTICES Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than June 7, 2019. A. Federal Reserve Bank of Kansas City (Dennis Denney, Assistant Vice VerDate Sep<11>2014 19:39 May 08, 2019 Jkt 247001 The Agency for Toxic Substances and Disease Registry (ATSDR), within the Department of Health and Human Services (HHS), announces the opening of a docket to obtain comments on Draft Toxicological Profiles for Dinitrophenols, 2-Butanone, Mirex and Chlordecone, 1,2Diphenylhydrazine, 1,2,3Trichloropropane, Lead, and Endrin. ATSDR has updated these profiles based on availability of new health effects information since their initial release. On March 21, 2016 ATSDR announced that it was preparing to develop Draft Toxicological Profiles for public comment release (81 FR 15110), which include those profiles mentioned above. All toxicological profiles issued as ‘‘Drafts for Public Comment’’ represent the result of ATSDR’s evidence-based evaluations to provide important toxicological information on priority hazardous substances. ATSDR is seeking public comments and additional information or reports on studies about the health effects of dinitrophenols, 2butanone, mirex and chlordecone, 1,2diphenylhydrazine, 1,2,3trichloropropane, lead, and endrin for review and potential inclusion in the profiles. ATSDR considers key studies for these substances during the profile development process. This document solicits any relevant, additional studies. ATSDR will evaluate the quality and relevance of such data or studies for possible inclusion into the profile. SUMMARY: PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 20359 Written comments must be received on or before August 7, 2019. ADDRESSES: You may submit comments, identified by docket number ATSDR– 2019–0006, by any of the following methods: • Federal eRulemaking Portal: www.regulations.gov. Follow the instructions for submitting comments. • Mail: Division of Toxicology and Human Health Sciences, Agency for Toxic Substances and Disease Registry, 1600 Clifton Rd. NE, Mail Stop S102–1, Atlanta, GA, 30329–4027. Attn: Docket No. ATSDR–2019–0006. Instructions: All submissions must include the agency name and Docket Number. All relevant comments received will be posted without change to http://regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to http://www.regulations.gov. FOR FURTHER INFORMATION CONTACT: Susan Ingber, Agency for Toxic Substances and Disease Registry, Division of Toxicology and Human Health Sciences, 1600 Clifton Rd. NE, Mail Stop S102–1, Atlanta, GA, 30329– 4027, Email: ATSDRToxProfileFRNs@ cdc.gov; Phone: 1–800–232–4636. SUPPLEMENTARY INFORMATION: DATES: Public Participation Interested persons or organizations are invited to participate by submitting written views, information, and data. Please note that comments received, including attachments and other supporting materials, are part of the public record and are subject to public disclosure. Comments will be posted on https://www.regulations.gov. Therefore, do not include any information in your comment or supporting materials that you consider confidential or inappropriate for public disclosure. If you include your name, contact information, or other information that identifies you in the body of your comments, that information will be on public display. ATSDR will review all submissions and may choose to redact, or withhold, submissions containing private or proprietary information such as Social Security numbers, medical information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. ATSDR will carefully consider all comments submitted in preparation of the final Toxicological Profiles and may revise the profiles as appropriate. Legislative Background The Superfund Amendments and Reauthorization Act of 1986 (SARA) [42 E:\FR\FM\09MYN1.SGM 09MYN1 20360 Federal Register / Vol. 84, No. 90 / Thursday, May 9, 2019 / Notices U.S.C. 9601 et seq.] amended the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA or Superfund) [42 U.S.C. 9601 et seq.] by establishing certain requirements for ATSDR and the U.S. Environmental Protection Agency (EPA) regarding hazardous substances that are most commonly found at facilities on the CERCLA National Priorities List (NPL). Among these statutory requirements is a mandate for the Administrator of ATSDR to prepare toxicological profiles for each substance included on the priority list of hazardous substances [also called the Substance Priority List (SPL)]. This list identifies 275 hazardous substances that ATSDR and EPA have determined pose the most significant potential threat to human health. The SPL is available online at www.atsdr.cdc.gov/spl. In addition, CERCLA provides ATSDR with the authority to prepare toxicological profiles for substances not found on the SPL. CERCLA authorizes ATSDR to establish and maintain an inventory of literature, research, and studies on the health effects of toxic substances (CERCLA Section 104(i)(1)(B); 42 U.S.C. 9604(i)(1)(B)); to respond to requests for health consultations (CERCLA Section 104(i)(4); 42 U.S.C. 9604(i)(4)); and to support the site-specific response actions conducted by the agency. Availability These Draft Toxicological Profiles will be available online at http:// www.atsdr.cdc.gov/ToxProfiles and at www.regulations.gov, Docket No. ATSDR–2019–0006. Pamela I. Protzel Berman, Director, Office of Policy, Partnerships and Planning, Agency for Toxic Substances and Disease Registry. [FR Doc. 2019–09538 Filed 5–8–19; 8:45 am] BILLING CODE 4163–70–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Community Living jbell on DSK3GLQ082PROD with NOTICES Statement of Organization, Functions, and Delegations of Authority Part B of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (HHS), as last amended at 79 FR 80 FR 31389–31402, dated June 2, 2015, is amended to reflect the reorganization of the Administration on Community Living (ACL). This reorganization is being undertaken to VerDate Sep<11>2014 19:39 May 08, 2019 Jkt 247001 improve efficiency and effectiveness of the organization; strengthen infrastructure; and improve the connections between the organization and its stakeholder, grantees and consumers at the national, state and local levels. It changes the Office of Elder Justice and Adult Protective Services functions to include carrying out the Long-Term Care Ombudsman functions established in Section 201(d)(1) of the Older Americans Act (OAA) and the Deputy Assistant Secretary for Aging will meet the responsibilities for the Director of the Office of Long-Term Care Ombudsman Programs. It renames the Independent Living Administration to the Office of Independent Living Programs, which will continue to serve as the Independent Living Administration as specified in Section 701A of the Rehabilitation Act, and renames the Administration on Intellectual and Developmental Disabilities to the Office of Intellectual and Developmental Disabilities Programs. The Commissioner for the Administration on Disabilities (AoD) will also serve as the Director of the Independent Living Admininstration. It retitles the Center for Integrated Programs to the Center for Innovation and Partnership, the Office of Consumer Access and SelfDetermination to the Office of Network Advancement, and the Office of Integrated Care Innovations to the Office of Interagency Innovation. It retitles the National Institute of Disability, Independent Living and Rebabilitation Research’s Office of Research Evaluation and Administration to the Office of Research Administration. It retitles the Office of Regional Operations to the Center for Regional Operations. The changes are as follows: I. Under Section B10, Organization, delete Center for Integrated Programs (BD) and replace with Center for Innovation and Partnership (BD). II. Delete Section B20, Functions, in its entirety and replace with the following: B.20 Functions. ACL is the principal agency in the department designated to lead aging and disability programs. More specifically, the provisions of the Older Americans Act (OAA) of 1965 are carried out by its subcomponent, the Administration on Aging (AoA); the provisions of the Developmental Disabilities Assistance and Bill of Rights Act (DD Act) of 2000 and Title VII of the Rehabilitation Act of 1973 are carried out by its subcomponent, the Administration on Disabilities (AoD); and the provisions of Title II of the Rehabilitation Act of 1973 are carried out by its subcomponent, the National Institute on Disability, Independent Living, and Rehabilitation Research. ACL also administers programs PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 authorized under Title III and Title XXIX of the Public Health Service Act (PHSA), section 262 and 292 of the Help America Vote Act (HAVA), section 119 of the Medicare Improvements for Patients and Providers Act (MIPPA) of 2008, section 6021(d) of the Deficit Reduction Act (DRA) of 2005, section 4360 of the Omnibus Budget Reconciliation Act (OBRA) of 1990, the Elder Justice Act (EJA) of 2010 (Subtitle B of Title XX of the Social Security Act), the Assistive Technology Act of 1998, and the Traumatic Brain Injury Program Reauthorization Act of 2018. In addition, ACL provides continuing support for the administration of the President’s Committee for People with Intellectual Disabilities pursuant to E.O. 13652. Specifically, ACL: Develops, recommends and issues regulations, policies, procedures, standards and guidelines to provide direction for the programs it administers. Approves or disapproves plans and funding applications for national programs providing communitybased long-term services and supports. Administers programs for training, research, demonstration, evaluation and information dissemination. Administers programs related to advocacy, systems change and capacity building. Administers national centers for service development and provides technical assistance to states, tribal organizations, local communities and service providers. Serves as the lead federal agency for adult protective services. Assists the Secretary in all matters pertaining to opportunities and challenges of persons with disabilities, older Americans, and Americans of all ages about their current and potential future need for information and access to long-term services and supports. Advocates for the needs of these constituencies in program planning and policy development within the department and in other federal agencies. Advises the Secretary, departmental components and other federal organizations on the characteristics, circumstances and needs of these populations and develops policies, plans and programs designed to promote their welfare. The functions of the organizational units of ACL are described in detail in the succeeding chapters. III. Under Section BA.20, Functions, delete Subsection 3. Office of Regional Operations (BAC) in its entirety. IV. Delete Section B, Administration on Aging (BB), in its entirety and replace with the following: B. Administration on Aging (BB) BB.00 Mission BB.10 Organization BB.20 Functions BB.00 Mission. The Administration on Aging (AoA) carries out programs operated under the OAA, Sections III, XXIX and 398 of the PHSA, and the EJA (Subtitle B of Title XX of the Social Security), including, but not limited to, those concerning the Elder Justice Coordinating Council and Adult Protective Services. The AoA helps elderly individuals maintain their dignity and independence in their homes and communities through comprehensive, coordinated, and cost E:\FR\FM\09MYN1.SGM 09MYN1

Agencies

[Federal Register Volume 84, Number 90 (Thursday, May 9, 2019)]
[Notices]
[Pages 20359-20360]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-09538]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Toxic Substances and Disease Registry

[Docket No. ATSDR-2019-0006]


Availability of Draft Toxicological Profiles

AGENCY: Agency for Toxic Substances and Disease Registry (ATSDR), 
Department of Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Agency for Toxic Substances and Disease Registry (ATSDR), 
within the Department of Health and Human Services (HHS), announces the 
opening of a docket to obtain comments on Draft Toxicological Profiles 
for Dinitrophenols, 2-Butanone, Mirex and Chlordecone, 1,2-
Diphenylhydrazine, 1,2,3-Trichloropropane, Lead, and Endrin. ATSDR has 
updated these profiles based on availability of new health effects 
information since their initial release. On March 21, 2016 ATSDR 
announced that it was preparing to develop Draft Toxicological Profiles 
for public comment release (81 FR 15110), which include those profiles 
mentioned above. All toxicological profiles issued as ``Drafts for 
Public Comment'' represent the result of ATSDR's evidence-based 
evaluations to provide important toxicological information on priority 
hazardous substances. ATSDR is seeking public comments and additional 
information or reports on studies about the health effects of 
dinitrophenols, 2-butanone, mirex and chlordecone, 1,2-
diphenylhydrazine, 1,2,3-trichloropropane, lead, and endrin for review 
and potential inclusion in the profiles. ATSDR considers key studies 
for these substances during the profile development process. This 
document solicits any relevant, additional studies. ATSDR will evaluate 
the quality and relevance of such data or studies for possible 
inclusion into the profile.

DATES: Written comments must be received on or before August 7, 2019.

ADDRESSES: You may submit comments, identified by docket number ATSDR-
2019-0006, by any of the following methods:
     Federal eRulemaking Portal: www.regulations.gov. Follow 
the instructions for submitting comments.
     Mail: Division of Toxicology and Human Health Sciences, 
Agency for Toxic Substances and Disease Registry, 1600 Clifton Rd. NE, 
Mail Stop S102-1, Atlanta, GA, 30329-4027. Attn: Docket No. ATSDR-2019-
0006.
    Instructions: All submissions must include the agency name and 
Docket Number. All relevant comments received will be posted without 
change to http://regulations.gov, including any personal information 
provided. For access to the docket to read background documents or 
comments received, go to http://www.regulations.gov.

FOR FURTHER INFORMATION CONTACT: Susan Ingber, Agency for Toxic 
Substances and Disease Registry, Division of Toxicology and Human 
Health Sciences, 1600 Clifton Rd. NE, Mail Stop S102-1, Atlanta, GA, 
30329-4027, Email: [email protected]; Phone: 1-800-232-4636.

SUPPLEMENTARY INFORMATION:

Public Participation

    Interested persons or organizations are invited to participate by 
submitting written views, information, and data.
    Please note that comments received, including attachments and other 
supporting materials, are part of the public record and are subject to 
public disclosure. Comments will be posted on https://www.regulations.gov. Therefore, do not include any information in your 
comment or supporting materials that you consider confidential or 
inappropriate for public disclosure. If you include your name, contact 
information, or other information that identifies you in the body of 
your comments, that information will be on public display. ATSDR will 
review all submissions and may choose to redact, or withhold, 
submissions containing private or proprietary information such as 
Social Security numbers, medical information, inappropriate language, 
or duplicate/near duplicate examples of a mass-mail campaign. ATSDR 
will carefully consider all comments submitted in preparation of the 
final Toxicological Profiles and may revise the profiles as 
appropriate.

Legislative Background

    The Superfund Amendments and Reauthorization Act of 1986 (SARA) [42

[[Page 20360]]

U.S.C. 9601 et seq.] amended the Comprehensive Environmental Response, 
Compensation, and Liability Act of 1980 (CERCLA or Superfund) [42 
U.S.C. 9601 et seq.] by establishing certain requirements for ATSDR and 
the U.S. Environmental Protection Agency (EPA) regarding hazardous 
substances that are most commonly found at facilities on the CERCLA 
National Priorities List (NPL). Among these statutory requirements is a 
mandate for the Administrator of ATSDR to prepare toxicological 
profiles for each substance included on the priority list of hazardous 
substances [also called the Substance Priority List (SPL)]. This list 
identifies 275 hazardous substances that ATSDR and EPA have determined 
pose the most significant potential threat to human health. The SPL is 
available online at www.atsdr.cdc.gov/spl.
    In addition, CERCLA provides ATSDR with the authority to prepare 
toxicological profiles for substances not found on the SPL. CERCLA 
authorizes ATSDR to establish and maintain an inventory of literature, 
research, and studies on the health effects of toxic substances (CERCLA 
Section 104(i)(1)(B); 42 U.S.C. 9604(i)(1)(B)); to respond to requests 
for health consultations (CERCLA Section 104(i)(4); 42 U.S.C. 
9604(i)(4)); and to support the site-specific response actions 
conducted by the agency.

Availability

    These Draft Toxicological Profiles will be available online at 
http://www.atsdr.cdc.gov/ToxProfiles and at www.regulations.gov, Docket 
No. ATSDR-2019-0006.

Pamela I. Protzel Berman,
Director, Office of Policy, Partnerships and Planning, Agency for Toxic 
Substances and Disease Registry.
[FR Doc. 2019-09538 Filed 5-8-19; 8:45 am]
 BILLING CODE 4163-70-P